DK1331935T3 - Derivater af tryptamin og analoge forbindelser samt farmaceutiske formuleringer deraf - Google Patents

Derivater af tryptamin og analoge forbindelser samt farmaceutiske formuleringer deraf

Info

Publication number: DK1331935T3
Authority: DK; Denmark
Prior art keywords: tryptamine; derivatives; well; pharmaceutical formulations; analogous compounds
Prior art date: 2000-10-03

Application number

DK01974651T

Other languages

Danish (da)

English (en)

Inventor

Nava Zisapel

Moshe Laudon

Original Assignee

Neurim Pharma 1991

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-03

Filing date

2001-09-25

Publication date

2009-02-02

2001-09-25 Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991

2009-02-02 Application granted granted Critical

2009-02-02 Publication of DK1331935T3 publication Critical patent/DK1331935T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Reproductive Health (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Psychiatry (AREA)
Immunology (AREA)
Psychology (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Hospice & Palliative Care (AREA)
Ophthalmology & Optometry (AREA)
Vascular Medicine (AREA)
Anesthesiology (AREA)
Emergency Medicine (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK01974651T 2000-10-03 2001-09-25 Derivater af tryptamin og analoge forbindelser samt farmaceutiske formuleringer deraf DK1331935T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IL138825A IL138825A (en)	2000-10-03	2000-10-03	Pharmaceutical preparations containing tryptamine derivatives and similar compounds, and such new compounds
PCT/IL2001/000898 WO2002028347A2 (fr)	2000-10-03	2001-09-25	Derives de tryptamines et composes analogues, et formulation pharmaceutique contenant de tels derives

Publications (1)

Publication Number	Publication Date
DK1331935T3 true DK1331935T3 (da)	2009-02-02

Family

ID=11074694

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01974651T DK1331935T3 (da)	2000-10-03	2001-09-25	Derivater af tryptamin og analoge forbindelser samt farmaceutiske formuleringer deraf

Country Status (39)

Country	Link
US (2)	US6780884B2 (fr)
EP (1)	EP1331935B1 (fr)
JP (1)	JP2004533986A (fr)
KR (1)	KR100855385B1 (fr)
CN (1)	CN100518735C (fr)
AR (1)	AR035587A1 (fr)
AT (1)	ATE409474T1 (fr)
AU (1)	AU9416201A (fr)
BG (1)	BG107759A (fr)
BR (1)	BR0114464A (fr)
CA (1)	CA2423628C (fr)
CL (1)	CL2001002303A1 (fr)
CR (1)	CR6968A (fr)
CY (1)	CY1110417T1 (fr)
CZ (1)	CZ301098B6 (fr)
DE (1)	DE60136003D1 (fr)
DK (1)	DK1331935T3 (fr)
EA (1)	EA005918B1 (fr)
EE (1)	EE05192B1 (fr)
ES (1)	ES2315307T3 (fr)
GT (1)	GT200100197A (fr)
HN (1)	HN2001000218A (fr)
HU (1)	HU227163B1 (fr)
IL (1)	IL138825A (fr)
IS (1)	IS2607B (fr)
MX (1)	MXPA03002612A (fr)
NO (1)	NO20031396D0 (fr)
NZ (1)	NZ525587A (fr)
PA (1)	PA8529801A1 (fr)
PE (1)	PE20020411A1 (fr)
PL (1)	PL365679A1 (fr)
PT (1)	PT1331935E (fr)
SI (1)	SI1331935T1 (fr)
SK (1)	SK4042003A3 (fr)
TW (1)	TWI270544B (fr)
UA (1)	UA75091C2 (fr)
UY (1)	UY26946A1 (fr)
WO (1)	WO2002028347A2 (fr)
ZA (1)	ZA200303113B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1694323A4 (fr) *	2003-12-19	2009-05-13	Elixir Pharmaceuticals Inc	Procedes de traitement d'un trouble
EP1715742A4 (fr) *	2004-02-20	2009-06-17	Lifescape Biosciences Inc	Compositions et methodes de regulation du sommeil
US20070015814A1 (en) *	2005-06-10	2007-01-18	Ernest Kun	Parp Modulators and Treatment of Cancer
US7622495B2 (en)	2006-10-03	2009-11-24	Neurim Pharmaceuticals (1991) Ltd.	Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents
WO2009003226A1 (fr)	2007-06-29	2009-01-08	Clarencew Pty Ltd	Traitement ou prophylaxie de troubles neurologiques ou neuropsychiatriques par une administration oculaire
PT2291659E (pt) *	2008-05-13	2016-01-22	Univ Yale	Moléculas quiméricas pequenas para o recrutamento de anticorpos contra células cancerosas
US8852630B2 (en)	2008-05-13	2014-10-07	Yale University	Chimeric small molecules for the recruitment of antibodies to cancer cells
AU2012264320A1 (en)	2011-05-31	2014-01-23	Clarencew Pty.Ltd	Methods for preventing and treating motor-related neurological conditions
WO2013063492A1 (fr)	2011-10-28	2013-05-02	Board Of Regents, The University Of Texas System	Nouvelles compositions et procédés pour traiter le cancer
CN102816103B (zh) *	2012-08-20	2014-05-07	冉瑞琼	硫化天冬氨酸修饰的退黑素衍生物及其应用
RU2750989C2 (ru) *	2016-03-14	2021-07-07	Сомалоджик, Инк.	Композиции и способы синтеза 5-(n-защищенного триптаминкарбоксамида)-2'-дезоксиуридинфосфорамидита для включения в нуклеиновую кислоту
CN116421600B (zh) *	2023-05-29	2024-08-23	重庆医科大学	色醇在制备治疗焦虑的药物中的应用
WO2025137730A1 (fr) *	2023-12-22	2025-06-26	Alexander Shulgin Research Institute, Inc.	Tryptamines n-substituées et lysergamides n-substitués et leur utilisation comme agents thérapeutiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL79264A0 (en) *	1986-06-27	1986-09-30	Univ Ramot	Tryptamine derivatives,pharmaceutical compositions containing them and their use in an assay for melatonin receptors
AUPO274596A0 (en) *	1996-10-04	1996-10-31	Armstrong, Stuart Maxwell	Method for the treatment of neurological or neuropsychiatric disorders
US6310085B1 (en) *	1997-10-03	2001-10-30	Clarencew Pty Ltd.	Method for the treatment of neurological or neuropsychiatric disorders

2000
- 2000-10-03 IL IL138825A patent/IL138825A/en not_active IP Right Cessation
2001
- 2001-09-14 TW TW090122940A patent/TWI270544B/zh not_active IP Right Cessation
- 2001-09-25 CL CL2001002303A patent/CL2001002303A1/es unknown
- 2001-09-25 UA UA2003043421A patent/UA75091C2/uk unknown
- 2001-09-25 EE EEP200300135A patent/EE05192B1/xx not_active IP Right Cessation
- 2001-09-25 MX MXPA03002612A patent/MXPA03002612A/es active IP Right Grant
- 2001-09-25 AU AU9416201A patent/AU9416201A/xx not_active Withdrawn
- 2001-09-25 US US10/381,976 patent/US6780884B2/en not_active Expired - Fee Related
- 2001-09-25 DK DK01974651T patent/DK1331935T3/da active
- 2001-09-25 KR KR1020037004661A patent/KR100855385B1/ko not_active Expired - Fee Related
- 2001-09-25 PT PT01974651T patent/PT1331935E/pt unknown
- 2001-09-25 HU HU0302616A patent/HU227163B1/hu not_active IP Right Cessation
- 2001-09-25 WO PCT/IL2001/000898 patent/WO2002028347A2/fr not_active Ceased
- 2001-09-25 DE DE60136003T patent/DE60136003D1/de not_active Expired - Lifetime
- 2001-09-25 AT AT01974651T patent/ATE409474T1/de active
- 2001-09-25 EP EP01974651A patent/EP1331935B1/fr not_active Expired - Lifetime
- 2001-09-25 CZ CZ20030940A patent/CZ301098B6/cs not_active IP Right Cessation
- 2001-09-25 NZ NZ525587A patent/NZ525587A/en unknown
- 2001-09-25 CN CNB018168043A patent/CN100518735C/zh not_active Expired - Fee Related
- 2001-09-25 UY UY26946A patent/UY26946A1/es not_active Application Discontinuation
- 2001-09-25 SK SK404-2003A patent/SK4042003A3/sk unknown
- 2001-09-25 JP JP2002531973A patent/JP2004533986A/ja active Pending
- 2001-09-25 CA CA2423628A patent/CA2423628C/fr not_active Expired - Fee Related
- 2001-09-25 SI SI200130889T patent/SI1331935T1/sl unknown
- 2001-09-25 EA EA200300436A patent/EA005918B1/ru not_active IP Right Cessation
- 2001-09-25 PL PL01365679A patent/PL365679A1/xx not_active Application Discontinuation
- 2001-09-25 AR ARP010104520A patent/AR035587A1/es unknown
- 2001-09-25 BR BR0114464-2A patent/BR0114464A/pt not_active Application Discontinuation
- 2001-09-25 ES ES01974651T patent/ES2315307T3/es not_active Expired - Lifetime
- 2001-09-26 PE PE2001000960A patent/PE20020411A1/es not_active Application Discontinuation
- 2001-09-27 GT GT200100197A patent/GT200100197A/es unknown
- 2001-10-01 PA PA20018529801A patent/PA8529801A1/es unknown
- 2001-10-02 HN HN2001000218A patent/HN2001000218A/es unknown
2003
- 2003-03-21 IS IS6752A patent/IS2607B/is unknown
- 2003-03-27 NO NO20031396A patent/NO20031396D0/no not_active Application Discontinuation
- 2003-04-23 ZA ZA200303113A patent/ZA200303113B/xx unknown
- 2003-04-24 BG BG107759A patent/BG107759A/bg unknown
- 2003-05-02 CR CR6968A patent/CR6968A/es unknown
2004
- 2004-08-20 US US10/921,823 patent/US20050020664A1/en not_active Abandoned
2008
- 2008-12-22 CY CY20081101480T patent/CY1110417T1/el unknown

Also Published As

Publication number	Publication date
EE05192B1 (et)	2009-08-17
IS6752A (is)	2003-03-21
NZ525587A (en)	2005-03-24
JP2004533986A (ja)	2004-11-11
CL2001002303A1 (es)	2010-06-25
IL138825A0 (en)	2001-10-31
US6780884B2 (en)	2004-08-24
EA005918B1 (ru)	2005-06-30
MXPA03002612A (es)	2004-04-02
CA2423628A1 (fr)	2002-04-11
IL138825A (en)	2006-06-11
CZ2003940A3 (cs)	2003-10-15
US20040029950A1 (en)	2004-02-12
CN100518735C (zh)	2009-07-29
EA200300436A1 (ru)	2003-10-30
NO20031396L (no)	2003-03-27
AU9416201A (en)	2002-04-15
WO2002028347A3 (fr)	2002-07-04
KR20030051689A (ko)	2003-06-25
ZA200303113B (en)	2004-07-23
PL365679A1 (en)	2005-01-10
PA8529801A1 (es)	2002-12-30
KR100855385B1 (ko)	2008-09-04
AR035587A1 (es)	2004-06-16
ES2315307T3 (es)	2009-04-01
PT1331935E (pt)	2009-01-19
EP1331935A2 (fr)	2003-08-06
NO20031396D0 (no)	2003-03-27
IS2607B (is)	2010-04-15
UY26946A1 (es)	2001-11-30
CA2423628C (fr)	2011-04-26
HUP0302616A2 (hu)	2003-11-28
EE200300135A (et)	2003-08-15
EP1331935A4 (fr)	2004-12-01
SI1331935T1 (sl)	2009-04-30
ATE409474T1 (de)	2008-10-15
WO2002028347A2 (fr)	2002-04-11
EP1331935B1 (fr)	2008-10-01
CZ301098B6 (cs)	2009-11-04
HK1074163A1 (zh)	2005-11-04
CR6968A (es)	2004-02-25
GT200100197A (es)	2002-05-08
UA75091C2 (en)	2006-03-15
CN1582147A (zh)	2005-02-16
SK4042003A3 (en)	2003-09-11
CY1110417T1 (el)	2015-04-29
HN2001000218A (es)	2002-05-09
TWI270544B (en)	2007-01-11
US20050020664A1 (en)	2005-01-27
DE60136003D1 (de)	2008-11-13
HU227163B1 (en)	2010-09-28
BR0114464A (pt)	2004-01-20
BG107759A (bg)	2004-01-30
PE20020411A1 (es)	2002-05-16

Publication	Publication Date	Title
IL162547A0 (en)	2005-11-20	Fused heterocyclic succinimide derivatives and pharmaceutical compositions containing the same
NO992339D0 (no)	1999-05-14	Farmas°ytiske formuleringer
DK1147083T3 (da)	2004-08-16	Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
IL156031A0 (en)	2003-12-23	Fused heterocyclic derivatives and pharmaceutical compositions containing the same
CY2016002I1 (el)	2016-10-05	Ν-υποκατεστημενο καρβαμουλοξυαλκυλιο - παραγωγα αζολιου
AR028280A1 (es)	2003-04-30	Derivados de 2-amino-3-(alquil)-pirimidona
AR028567A1 (es)	2003-05-14	Nuevos derivados de fenil-propargileter
IS6508A (is)	2002-08-16	Lyfjasamsetningar af glycogen fosfórýlasa lötum
NO20033556L (no)	2003-10-09	Farmasöytiske formuleringer
DK1427709T3 (da)	2006-04-03	3-substituerede 4-pyrimidonderivater
DK1237408T3 (da)	2004-06-28	Hæld-på-formuleringer
AR028596A1 (es)	2003-05-14	Nuevos derivados de fenilglicina
IL157740A0 (en)	2004-03-28	Heterocyclic derivatives and pharmaceutical compositions containing the same
NO20015670D0 (no)	2001-11-20	Forbedrede farmasöytiske formuleringer
ATE270270T1 (de)	2004-07-15	Neuartige phenylalkyloxy-phenyl-derivate
EE05375B1 (et)	2011-02-15	LevosimendaniÁfarmatseutilineÁlahus
FR2788964B1 (fr)	2001-04-20	Insert tibial anti-basculement
DK1331935T3 (da)	2009-02-02	Derivater af tryptamin og analoge forbindelser samt farmaceutiske formuleringer deraf
IS6398A (is)	2002-05-27	Lyfjablöndur
GB0026578D0 (en)	2000-12-13	Heterocyclic derivatives useful as pharmaceutical agents
PT1322592E (pt)	2004-12-31	Derivados substituidos de 1-aminobutan-3-ol
ATE231865T1 (de)	2003-02-15	Imidazodiazepinderivate
IL159085A0 (en)	2004-05-12	Heterocyclic derivatives and pharmaceutical compositions containing the same
PT1178984E (pt)	2003-06-30	Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
NO20022682D0 (no)	2002-06-06	Heterosykliske derivater